Key facts
- HIGHBRIDGE CAPITAL MANAGEMENT LLC filed SCHEDULE 13G/A for OnKure Therapeutics, Inc. Class A Common Stock, par value $0.0001 per share (OKUR).
- Disclosed ownership: 4.2%.
- Date of event: 31 Dec 2025.
HIGHBRIDGE CAPITAL MANAGEMENT LLC - 31 Dec 2025 SCHEDULE 13G/A Report for OnKure Therapeutics, Inc. Class A Common Stock, par value $0.0001 per share (OKUR)
- Filing manager
- HIGHBRIDGE CAPITAL MANAGEMENT LLC
- Reporting owner
- Highbridge Capital Management, LLC
- Symbol
- OKUR
- Shares outstanding
- 12,913,357 shares
- Disclosed shares
- 542,361 shares
- Ownership percentage
- 4.2%
- Form type
- SCHEDULE 13G/A
- Filing time
- 17 Feb 2026, 16:10:36 UTC
- Event date
- 31 Dec 2025
- Previous filing
- 14 Aug 2025
- SEC filing
- View on sec.gov
Reporting parties
Subject security
Ownership signal
SEC evidence
Key filing fact
HIGHBRIDGE CAPITAL MANAGEMENT LLC disclosed 4.2% ownership in OnKure Therapeutics, Inc. Class A Common Stock, par value $0.0001 per share (OKUR) on 31 Dec 2025.
Change
- Previous schedule filing date: 14 Aug 2025.
- Current filing was accepted on 17 Feb 2026, 16:10.
Research use
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Reporting managers (1)
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Highbridge Capital Management, LLC | 4.2% | 542,361 | 542,361 | 0 | /s/ Kirk Rule | Kirk Rule, Executive Director |
CIK / CUSIP context first